HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effects of a novel KATP channel opener JTV-506 on myocardial infarct size of isolated rat heart].

AbstractAIM:
To study the influence of a novel KATP channel opener JTV-506(JTV) on cardiac function and myocardial infarct size of isolated rat heart.
METHODS:
The Langendorff apparatus was used to study the effect of JTV at different concentrations on the flow of coronary artery and the pressure of left ventricle. The effect of JTV on infarction size was observed on the isolated rat double coronary arteries perfusion model.
RESULTS:
JTV 1 mumol.L-1 increased the flow of coronary artery obviously. When the concentration reached 10 mumol.L-1, JTV decreased the systolic pressure of the left ventricle. JTV 1 mumol.L-1 reduced the myocardial infarct size whether it was administrated during both preischemic and ischemic period or only during ischemic period. This effect was completely blocked by glibenclamide, but when glibenclamide was administrated alone, it showed no obvious effect on infarct size.
CONCLUSION:
The KATP channel opener JTV can obviously dilate coronary artery and decrease cardiac systolic function when administrated at high doses. JTV was found to decrease the infarct size when administrated in doses that did not affect cardiac function. These effects were related to the opening of KATP channel.
AuthorsD L Jia, X W Zheng, G X Qi, J Hu, D Y Zeng
JournalYao xue xue bao = Acta pharmaceutica Sinica (Yao Xue Xue Bao) Vol. 35 Issue 10 Pg. 743-6 (Oct 2000) ISSN: 0513-4870 [Print] China
PMID11372439 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Chromans
  • JTV 506
  • Potassium Channels
  • Vasodilator Agents
  • Glyburide
Topics
  • Animals
  • Chromans (pharmacology)
  • Coronary Circulation (drug effects)
  • Glyburide (pharmacology)
  • In Vitro Techniques
  • Male
  • Myocardial Infarction (pathology)
  • Potassium Channels (agonists)
  • Rats
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: